MARKET

DCOY

DCOY

DECOY THERAPEUTICS INC
NASDAQ
5.90
+0.31
+5.55%
Closed 19:45 06/11 EDT
OPEN
5.61
PREV CLOSE
5.59
HIGH
6.00
LOW
5.50
VOLUME
8.13K
TURNOVER
0
52 WEEK HIGH
415.80
52 WEEK LOW
4.320
MARKET CAP
3.14M
P/E (TTM)
-0.0058
1D
5D
1M
3M
1Y
5Y
1D
Decoy Therapeutics Inc trading resumes
TipRanks · 2d ago
Decoy Therapeutics Inc trading halted, volatility trading pause
TipRanks · 2d ago
Weekly Report: what happened at DCOY last week (0601-0605)?
Weekly Report · 3d ago
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga · 06/04 17:06
*Decoy Therapeutics: David Arthur Completing His Service on the Board >DCOY
Dow Jones · 06/03 12:02
DECOY THERAPEUTICS NOMINATES GLOBAL BIOPHARMA EXECUTIVE PATRICIA GAUTHIER FOR ELECTION TO BOARD OF DIRECTORS
Reuters · 06/03 12:00
Press Release: Decoy Therapeutics Nominates Global Biopharma Executive Patricia Gauthier for Election to Board of Directors
Dow Jones · 06/03 12:00
Decoy Therapeutics Partners With HVIVO To Advance D-MAV Into Clinical Study; Stock Up
NASDAQ · 06/01 14:45
More
About DCOY
Decoy Therapeutics Inc., formerly Salarius Pharmaceuticals, Inc., is a preclinical-stage biotechnology company that is leveraging machine learning and artificial intelligence (AI) tools alongside high-speed synthesis techniques to design, engineer and manufacture peptide conjugate drug candidates that target serious unmet medical needs. The Company’s initial pipeline is focused on respiratory viruses and GI cancers. In parallel, the Company is advancing discovery programs, including multi-virus decoy candidates designed to address overlapping respiratory threats, and cell-based and organoid-level validation of novel G protein-coupled receptor (GPCR)-targeted drug candidates outside of antivirals.

Webull offers Decoy Therapeutics Inc stock information, including NASDAQ: DCOY real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, DCOY stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading DCOY stock methods without spending real money on the virtual paper trading platform.